News & Events

News, industry insights and noteworthy events.

At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.

For media or press inquiries, please email us.

Contact Us

All Articles

  1. Tanner Pharma Directors to Attend Key International Healthcare Conferences in 2023

    Directors from Tanner Pharma Group will attend several international healthcare conferences in the coming weeks. Connect with our team members directly or via conference platforms to schedule meetings. We look forward to meeting with you. JPM Healthcare Conference 9-12 January | San Francisco, CA USA Attendees: Steve Scalia, John Lagus Medlab Middle East 6-9 February…

    Read More
  2. Max Global Experience: Cambodia

    In a heartwarming journey that embodies our commitment to improving global access to critical medicines, Tanner Pharma Group proudly served as the title sponsor for The Max Foundation’s “Max Global Experience: Cambodia.” This remarkable expedition, attended by our EVP of Managed Access Programs, Rob Keel, not only showcased the unique barriers that people face in…

    Read More
  3. Celebrating Impact: Tanner’s Annual Charity Golf Day

    Our Annual Charity Golf Day at Redbourn Golf Club is not just a day on the green; it’s a day of camaraderie and making an impact. This year’s event was truly special, and we’re happy to share a few highlights. Charities Close to Our Hearts This year we were proud to nominate three UK charities:…

    Read More
  4. Tanner Pharma Group Announces Start of Construction for Cutting-Edge US Operations Facility

    We are thrilled to share that Tanner Pharma Group is embarking on a new chapter of growth and expansion with the start of construction for a new, state-of-the-art operations facility in Charlotte, NC USA. This milestone signifies our unwavering commitment to enabling patient access and providing enhanced storage, distribution, and logistics capabilities to our partners…

    Read More
  5. Tanner Pharma Group Initiates a Global Innovative Named Patient Program for Zemdri

    Charlotte, NC, May 23, 2023 – Tanner Pharma Group and Cipla Therapeutics Inc. have jointly launched an innovative Named Patient Program (NPP) for Zemdri (plazomicin) Injection. The collaboration will expand access to Zemdri on a Named Patient basis in countries and regions where the drug is not yet commercially accessible, for patients 18 years of…

    Read More
  6. ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program for KIMOZO® (temozolomide) in European Countries

    PRESS RELEASE Paris (France) and Charlotte, N.C. (USA), on April 18th, 2023 – ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of pediatric and orphan medicines, and Tanner Pharma Group, a global provider of integrated specialty access solutions, have signed an exclusive agreement to manage the supply and distribution of Ped-TMZ,…

    Read More
  7. Tanner Pharma Group and ExeGi Pharma Announce Partnership to Distribute High Potency Probiotic in Mexico to Support Patients with Gut Microbiome Imbalance

    Rockville, M.D., and Charlotte, N.C., April 12, 2023 – ExeGi Pharma LLC (“ExeGi”), a leading developer of live biotherapeutic drugs and probiotics, has announced a partnership with TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, to distribute Visbiome® in Mexico. Visbiome® is a high-potency probiotic medical food that helps manage dysbiosis associated with medical…

    Read More
  8. Tanner Pharma Group to Distribute an Innovative Product that Protects and Repairs the Gastrointestinal Mucosa

    Teramo (Italy) and Charlotte, N.C. (USA), on April 3, 2023 – Azienda Farmaceutica Italiana (“AFI”), an Italian pharmaceutical company and innovator in therapeutic solutions and new treatment possibilities, and TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, have entered into a license agreement for the distribution of Hepilor® in Latin America. Hepilor® is a…

    Read More
  9. International Women’s Day 2023

    International Women’s Day (March 8) is a global day dedicated to celebrating the achievements of women and raising awareness about women’s equality. Learn more about what International Women’s Day means to some of our Tanner team members. What Does International Women’s Day Mean to You? “International Women’s Day is an opportunity to celebrate the givers…

    Read More
  10. The Chairman’s Award 2023: Gaby Bedoya

    The Chairman’s Award is Tanner’s highest accolade. It is awarded to the associate who goes above and beyond to meet the needs of our team and our partners, and exemplifies our Tanner values of determined and tenacious, resourceful and creative, and responsive and caring to further enable us to pursue our mission to improve patient…

    Read More
  11. Insights From a Multi-Stakeholder Discussion on Early Access Pathways to Medicine

    In partnership with RARE Revolution, Tanner Pharma Group co-hosted a webinar that brought together stakeholders to discuss early access pathways to medicines. Discussion topics covered the role of patient groups and healthcare professionals, communication strategies, real-world data collection, equitable access, ethical issues and patient pathways to access. Medicines that treat a particular rare disease may…

    Read More
  12. TannerCares Hosts Team Volunteer Event with Second Harvest Food Bank of Metrolina

    TannerCares is the philanthropic commitment of our company and was built as a means to support the causes of our partners and team members through the giving of time and financial resources. The Tanner Volunteer Program is a component of this initiative and serves as a way to strengthen our local communities and provide our…

    Read More
  13. Managing aggressive timelines for clinical trials on a global scale

    Sourcing clinical trial products and distributing them in accordance with strict timelines and country-specific regulations can make or break a trial’s success. And with more clinical trials taking place across several countries and within hard-to-reach regions, managing these requirements presents a range of complications for trial sponsors. In this article, we provide insights on clinical…

    Read More
  14. The impact of climate change on the pharma supply chain

    Climate change has the potential to cause major disruptions to the global pharma supply chain and tragic health impacts for the global population. Many in the pharma industry are making efforts to reduce emissions and implement more eco-friendly processes to ensure patients can continue to access their medicines efficiently and sustainably. Pharmaceutical supply chains are…

    Read More
  15. The Mexico Pharma Market: Growth factors and advantages for manufacturing

    Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages. We take a look at some of the factors behind the growth of the Mexican pharma market, and the challenges with meeting regulatory requirements. Mexico is Latin America’s second-largest pharmaceutical market…

    Read More
  16. The Brazilian Pharma Market: Key information and what may change

    Brazil has the largest pharmaceutical market in Latin America, and recent political changes have raised speculation about what other changes could be in store. We take a look at the country’s pharma market and explore what could be around the corner in terms of legislation. Brazil is the largest country in Latin America, with a…

    Read More
  17. Managing drug shortages: Getting medicines to patients in need

    Patients around the world are experiencing drug shortages, with production still recovering from the disruption caused by Covid-19, the war in Ukraine, and rising energy costs. Tanner Pharma is tackling these issues head-on, managing disruptions and ensuring that a range of treatments reach patients wherever they are. Ongoing drug shortages are not a new occurrence,…

    Read More
  18. Enabling access continuity of medical treatments for patients

    There are different instances where patients may experience interruptions in treatment access, entirely lose access they once had, or completely lack access to a commercialized medicine that just isn’t available where they live. The common denominator being that all factors are almost always beyond the patient’s control. Finding ways to mitigate and overcome these challenges…

    Read More
  19. Overcoming challenges with medical product classification in Latin America

    Classification of medical products can vary greatly from one country to another, especially in Latin America. To sell products in specific markets, product owners must understand where any differences lie in how they are categorized. Learn more about navigating these market complexities. Medical product expansion in emerging markets such as Latin America can be a…

    Read More

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.